Methods for screening and compounds that protect against amyloid diseases

Details for Australian Patent Application No. 2010204723 (hide)

Owner The Salk Institute for Biological Studies

Inventors Dillin, Andrew; Baiga, Thomas J.; Kapernick, Erik; Noel, Joseph P.

Agent FB Rice

Pub. Number AU-A-2010204723

PCT Pub. Number WO2010/083328

Priority 61/144,505 14.01.09 US

Filing date 14 January 2010

Wipo publication date 22 July 2010

International Classifications

C07D 241/08 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

18 August 2011 PCT application entered the National Phase

  PCT publication WO2010/083328 Priority application(s): WO2010/083328

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010204724-System and method for retransmission and fragmentation in a communication network

2010204706-Compositions and methods of use